PHARMARISE HOLDINGS CORPORATIONPHARMARISE HOLDINGS CORPORATIONPHARMARISE HOLDINGS CORPORATION

PHARMARISE HOLDINGS CORPORATION

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.56 B‬JPY
−52JPY
‪−351.00 M‬JPY
‪54.47 B‬JPY
‪3.27 M‬
Beta (1Y)
0.39
Employees (FY)
‪1.85 K‬
Change (1Y)
+293 +18.84%
Revenue / Employee (1Y)
‪29.47 M‬JPY
Net income / Employee (1Y)
‪−189.94 K‬JPY

About PHARMARISE HOLDINGS CORPORATION


CEO
Toshimichi Ohno
Headquarters
Tokyo
Founded
1984
ISIN
JP3802320006
FIGI
BBG000JJSP47
Pharmarise Holdings Corp. engages in the management of its group of dispensing pharmacies. It operates through the following segments: Dispensing Pharmacy, Sales, Storage and Management of Medical Documents, Medical Mall Management, and Other. The Dispensing Pharmacy segment manages dispensing pharmacies that provides prescription drugs to general patients. The Sales segment handles the operation of drug stores and convenience stores and offers over-the-counter drugs, sanitary materials, cosmetics, and daily miscellaneous goods. The Storage and Management of Medical Documents segment covers the storage and management of medical examination records of patients on behalf of medical institutions. The Medical Mall Management segment deals with businesses related to the medical mall operated by its subsidiary. The Others segment includes the dispatchment of personnel and system integration business. The company was founded on June 28, 1984 and is headquartered in Tokyo, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 2796 is 559 JPY — it has decreased by −0.71% in the past 24 hours. Watch PHARMARISE HOLDINGS CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange PHARMARISE HOLDINGS CORPORATION stocks are traded under the ticker 2796.
2796 stock has fallen by −5.73% compared to the previous week, the month change is a −9.40% fall, over the last year PHARMARISE HOLDINGS CORPORATION has showed a −12.24% decrease.
2796 reached its all-time high on May 2, 2013 with the price of 935 JPY, and its all-time low was 117 JPY and was reached on Dec 19, 2008. View more price dynamics on 2796 chart.
See other stocks reaching their highest and lowest prices.
2796 stock is 2.16% volatile and has beta coefficient of 0.39. Track PHARMARISE HOLDINGS CORPORATION stock price on the chart and check out the list of the most volatile stocks — is PHARMARISE HOLDINGS CORPORATION there?
Today PHARMARISE HOLDINGS CORPORATION has the market capitalization of ‪6.28 B‬, it has decreased by −2.70% over the last week.
Yes, you can track PHARMARISE HOLDINGS CORPORATION financials in yearly and quarterly reports right on TradingView.
PHARMARISE HOLDINGS CORPORATION is going to release the next earnings report on Dec 25, 2024. Keep track of upcoming events with our Earnings Calendar.
2796 net income for the last quarter is ‪−131.00 M‬ JPY, while the quarter before that showed ‪−528.00 M‬ JPY of net income which accounts for 75.19% change. Track more PHARMARISE HOLDINGS CORPORATION financial stats to get the full picture.
As of Dec 22, 2024, the company has ‪1.85 K‬ employees. See our rating of the largest employees — is PHARMARISE HOLDINGS CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMARISE HOLDINGS CORPORATION EBITDA is ‪1.87 B‬ JPY, and current EBITDA margin is 3.83%. See more stats in PHARMARISE HOLDINGS CORPORATION financial statements.
Like other stocks, 2796 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMARISE HOLDINGS CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMARISE HOLDINGS CORPORATION technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMARISE HOLDINGS CORPORATION stock shows the sell signal. See more of PHARMARISE HOLDINGS CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.